Related Experiment Video
Updated: Apr 18, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
[Neuroendocrine dysfunctions during psychopharmacological treatment: clinical presentations, diagnosis, risk factors
Abstract:
We present a review of the literature on clinical presentations, diagnosis, treatment and prevention of neuroendocrine dysfunctions (NED) in patients with mental disorders during psychopharmacological treatment. Prolactinemia syndrome, metabolic syndrome and dysthyreosis are considered. Risk factors for NED and practical recommendations on diagnostic and therapeutic approaches to NED minimization are presented.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

